NK cells and ILCs in tumor immunotherapy

免疫疗法 癌症研究 免疫系统 生物 免疫学
作者
Simona Sivori,Daniela Pende,Linda Quatrini,Gabriella Pietra,Mariella Della Chiesa,Paola Vacca,Nicola Tumino,Francesca Moretta,Maria Cristina Mingari,Franco Locatelli,Lorenzo Moretta
出处
期刊:Molecular Aspects of Medicine [Elsevier]
卷期号:80: 100870-100870 被引量:179
标识
DOI:10.1016/j.mam.2020.100870
摘要

Cells of the innate immunity play an important role in tumor immunotherapy. Thus, NK cells can control tumor growth and metastatic spread. Thanks to their strong cytolytic activity against tumors, different approaches have been developed for exploiting/harnessing their function in patients with leukemia or solid tumors. Pioneering trials were based on the adoptive transfer of autologous NK cell-enriched cell populations that were expanded in vitro and co-infused with IL-2. Although relevant results were obtained in patients with advanced melanoma, the effect was mostly limited to certain metastatic localizations, particularly to the lung. In addition, the severe IL-2-related toxicity and the preferential IL-2-induced expansion of Treg limited this type of approach. This limitation may be overcome by the use of IL-15, particularly of modified IL-15 molecules to improve its half-life and optimize the biological effects. Other approaches to harness NK cell function include stimulation via TLR, the use of bi- and tri-specific NK cell engagers (BiKE and TriKE) linking activating NK receptors (e.g. CD16) to tumor-associated antigens and even incorporating an IL-15 moiety (TriKE). As recently shown, in tumor patients, NK cells may also express inhibitory checkpoints, primarily PD-1. Accordingly, the therapeutic use of checkpoint inhibitors may unleash NK cells against PD-L1+ tumors. This effect may be predominant and crucial in tumors that have lost HLA cl-I expression, thus resulting "invisible" to T lymphocytes. Additional approaches in which NK cells may represent an important tool for cancer therapy, are to exploit the unique properties of the "adaptive" NK cells. These CD57+ NKG2C+ cells, despite their mature stage and a potent cytolytic activity, maintain a strong proliferating capacity. This property revealed to be crucial in hematopoietic stem cell transplantation (HSCT), particularly in the haplo-HSCT setting, to cure high-risk leukemias. T depleted haplo-HSCT (e.g. from one of the parents) allowed to save the life of thousands of patients lacking a HLA-compatible donor. In this setting, NK cells have been shown to play an essential role against leukemia cells and infections. Another major advance is represented by chimeric antigen receptor (CAR)-engineered NK cells. CAR-NK, different from CAR-T cells, may be obtained from allogeneic donors since they do not cause GvHD. Accordingly, they may represent "off-the-shelf" products to promptly treat tumor patients, with affordable costs. Different from NK cells, helper ILC (ILC1, ILC2 and ILC3), the innate counterpart of T helper cell subsets, remain rather ambiguous with respect to their anti-tumor activity. A possible exception is represented by a subset of ILC3: their frequency in peri-tumoral tissues in patients with NSCLC directly correlates with a better prognosis, possibly reflecting their ability to contribute to the organization of tertiary lymphoid structures, an important site of T cell-mediated anti-tumor responses. It is conceivable that innate immunity may significantly contribute to the major advances that immunotherapy has ensured and will continue to ensure to the cure of cancer.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
陈爱佳发布了新的文献求助10
1秒前
roomvinli完成签到,获得积分10
1秒前
1秒前
元恪颜发布了新的文献求助10
1秒前
尉迟逸雪完成签到,获得积分10
3秒前
3秒前
隐形初曼发布了新的文献求助10
3秒前
4秒前
浅笑完成签到,获得积分10
4秒前
酷波er应助清秀的初翠采纳,获得10
5秒前
研友_VZG7GZ应助米娅采纳,获得20
5秒前
满唐完成签到 ,获得积分10
5秒前
研友_VZG7GZ应助帮帮我采纳,获得10
6秒前
心海应助ykiiii采纳,获得10
6秒前
7秒前
辰叶发布了新的文献求助10
7秒前
奔跑的小鹰完成签到,获得积分10
7秒前
深情安青应助小~杰采纳,获得10
7秒前
7秒前
支代桃完成签到,获得积分10
8秒前
shenzhou9发布了新的文献求助10
8秒前
奶味蓝发布了新的文献求助10
8秒前
10秒前
snow发布了新的文献求助10
11秒前
11秒前
zrj完成签到,获得积分10
11秒前
12秒前
活力的妙之完成签到 ,获得积分10
13秒前
鱼柒完成签到 ,获得积分10
13秒前
晚心发布了新的文献求助10
14秒前
CodeCraft应助小白采纳,获得10
14秒前
知还发布了新的文献求助10
14秒前
jiaoer完成签到,获得积分10
14秒前
14秒前
15秒前
dropofwater完成签到,获得积分10
15秒前
sss2021完成签到,获得积分10
16秒前
16秒前
quanjiazhi完成签到,获得积分10
17秒前
18秒前
高分求助中
The late Devonian Standard Conodont Zonation 2000
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 2000
The Lali Section: An Excellent Reference Section for Upper - Devonian in South China 1500
Very-high-order BVD Schemes Using β-variable THINC Method 870
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 800
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
Fundamentals of Dispersed Multiphase Flows 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3253860
求助须知:如何正确求助?哪些是违规求助? 2896294
关于积分的说明 8291677
捐赠科研通 2565096
什么是DOI,文献DOI怎么找? 1392804
科研通“疑难数据库(出版商)”最低求助积分说明 652299
邀请新用户注册赠送积分活动 629712